ATZ.TO vs. VRNA

Last updated Jul 25, 2026

ATZ.TO (Aritzia Inc.) and VRNA (Verona Pharma plc) are both stocks. ATZ.TO operates in Apparel Retail (Consumer Cyclical), while VRNA operates in Biotechnology (Healthcare). At a 0.07 correlation, their price movements are largely independent.

Performance

ATZ.TO vs. VRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Aritzia Inc. (ATZ.TO) and Verona Pharma plc (VRNA). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

ATZ.TO is traded in CAD, while VRNA is traded in USD. To make them comparable, the VRNA values have been converted to CAD using the latest available exchange rates.

Returns By Period

ATZ.TO

• 1D: 1.22%
• 1M: -12.50%
• 6M: 12.48%
• YTD: 14.61%
• 1Y: 81.66%
• 3Y*: 74.67%
• 5Y*: 29.87%
• 10Y*: —
• ALL TIME*: 22.13%

VRNA

• 1D: —
• 1M: —
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ATZ.TO Aritzia Inc.	CA$120.34M	CA$138.94M	CA$113.15M

ATZ.TO vs. VRNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ATZ.TO Aritzia Inc.	14.61%	119.59%	94.33%	-41.92%	-9.55%	102.99%	35.38%	16.16%	29.24%	-10.38%
VRNA Verona Pharma plc	0.00%	123.73%	153.38%	-25.73%	313.48%	-4.05%	18.85%	-42.87%	-11.87%	-18.87%

Correlation

The correlation between ATZ.TO and VRNA is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.02
Correlation (3Y) Calculated over the trailing 3-year period	0.06
Correlation (5Y) Calculated over the trailing 5-year period	0.12
Correlation (All Time) Calculated using the full available price history since Apr 27, 2017	0.07

The correlation between ATZ.TO and VRNA shifts across timeframes, from -0.02 (1 year) to 0.12 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ATZ.TO : CA$12.95B VRNA : $9.72B
EPS ATZ.TO : CA$5.09 VRNA : -$0.69
PS Ratio ATZ.TO : 3.03 VRNA : 57.97
Total Revenue (TTM) ATZ.TO : CA$3.99B VRNA : $167.65M
Gross Profit (TTM) ATZ.TO : CA$1.81B VRNA : $159.52M
EBITDA (TTM) ATZ.TO : CA$884.11M VRNA : -$40.86M

Return for Risk

ATZ.TO vs. VRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ATZ.TO

ATZ.TO Risk / Return Rank: 90
ATZ.TO Sharpe Ratio Rank: 93
ATZ.TO Sortino Ratio Rank: 89
ATZ.TO Omega Ratio Rank: 88
ATZ.TO Calmar Ratio Rank: 90
ATZ.TO Martin Ratio Rank: 89

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ATZ.TO vs. VRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aritzia Inc. (ATZ.TO) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ATZ.TO	VRNA	Difference
Sharpe ratio: Return per unit of total volatility	2.08	—	—
Sortino ratio: Return per unit of downside risk	2.62	—	—
Omega ratio: Gain probability vs. loss probability	1.33	—	—
Calmar ratio: Return relative to maximum drawdown	3.53	—	—
Martin ratio: Return relative to average drawdown	8.83	—	—

Drawdowns

Drawdown Indicators

	ATZ.TO	VRNA	Difference
Max Drawdown Largest peak-to-trough decline	-64.82%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-23.28%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-46.84%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-64.82%	—	—
Current Drawdown Current decline from peak	-22.34%	—	—
Average Drawdown Average peak-to-trough decline	-20.03%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	9.28%	—	—

Volatility

Volatility by Period

	ATZ.TO	VRNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.46%	—	—
Volatility (6M) Calculated over the trailing 6-month period	32.43%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	39.49%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	47.04%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	43.12%	—	—

Dividends

ATZ.TO vs. VRNA - Dividend Comparison

Neither ATZ.TO nor VRNA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

ATZ.TO vs. VRNA - Profitability Comparison

The chart below illustrates the profitability comparison between Aritzia Inc. and Verona Pharma plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Portfolio components

ATZ.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Aritzia Inc. reported a gross profit of 478.03M and revenue of 951.01M. Therefore, the gross margin over that period was 50.3%.

VRNA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Verona Pharma plc reported a gross profit of 71.68M and revenue of 75.14M. Therefore, the gross margin over that period was 95.4%.

ATZ.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Aritzia Inc. reported an operating income of 151.24M and revenue of 951.01M, resulting in an operating margin of 15.9%.

VRNA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Verona Pharma plc reported an operating income of 9.69M and revenue of 75.14M, resulting in an operating margin of 12.9%.

ATZ.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Aritzia Inc. reported a net income of 117.26M and revenue of 951.01M, resulting in a net margin of 12.3%.

VRNA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Verona Pharma plc reported a net income of 8.69M and revenue of 75.14M, resulting in a net margin of 11.6%.

Frequently Asked Questions

Can I hold both ATZ.TO and VRNA in my portfolio?

ATZ.TO and VRNA have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.